EUVIMEDEUVIMED entdecken
Crossref

The role of uremic toxin indoxyl sulfate in the pathophysiology of aortic valve stenosis

Philip Düsing iD, Isabel Göbel, Ansgar Ackerschott iD, Laurine Reese, Patrick Giavalisco, Frederik Dethloff, Sven Thomas Niepmann, Marta Stei, Thomas Beiert, Sebastian Zimmer iD, Christian Kurts, Georg Nickenig und 2 weitere

Cardiovascular Research · 2025

DOI: 10.1093/cvr/cvaf106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Philip Düsing und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, Heart Center, University Hospital Bonn, Medizinische Klinik und Poliklinik II, Venusberg Campus 1, Bonn 53127, Ge…. Hauptthemen laut MEDLINE: Indican, Aortic Valve, Aortic Valve Stenosis, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: University of Bonn, German Cardiac Society, Corona-Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Chronic kidney disease (CKD) is closely associated with cardiovascular disease (CVD). This includes aortic valve stenosis (AS), one of the most common valve diseases among adults. CKD leads to the retention of uremic toxins such as indoxyl sulfate (IS), which is known to induce inflammatory and pro-calcific processes. We hypothesize that IS specifically induces AS formation. Methods and results Stimulation of human valvular interstitial cells (VICs) with IS in addition to phosphate led to increased calcification. RNA sequencing identified naked cuticle homologue 2 (NKD2) as an up-regulated gene in VICs under uremic conditions. Knockdown of NKD2 reduced calcification of VICs and upregulation of IL-6. The organic anion transporting polypeptide 3A1 (OAT3A1) was identified to mediate IS uptake as well as upregulation of NKD2 and IL-6. We identified NF-κB signalling to be involved in IS-induced IL-6 upregulation. In vivo, we investigated combined models of adenine-induced kidney injury or oral IS supplementation with wire injury-induced AS in C57BL/6J mice. Echocardiography showed aggravated AS in uremic mice compared with control mice after wire injury. Explanted valves from uremic mice with AS exhibited a significant increase in macrophage infiltration, fibrotic areas and valvular NKD2 expression compared with controls. IS-treated mice showed aggravated AS compared with control mice. This was accompanied by more prominent valve fibrosis, macrophage infiltration, and NKD2 expression in explanted valves of IS-treated mice. In the blood and bone marrow, IS treatment led to the differentiation of monocytes into intermediate and non-classical monocytes. This was paralleled by IS-induced monocyte adhesion to valvular endothelial cells in vitro.

Conclusion

Uremic conditions aggravate AS development in mice by inducing valvular fibrosis and macrophage infiltration. IS is involved in this process and stimulates monocyte differentiation and adhesion to the valvular endothelium. On a cellular level, we hypothesize that IS-mediated NKD2 induction leads to a calcifying and inflammatory response in VICs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndicanAortic ValveAortic Valve StenosisRenal Insufficiency, ChronicCalcinosisUremiaUremic ToxinsAnimalsHumansMice, Inbred C57BLDisease Models, AnimalSignal TransductionInterleukin-6Cells, CulturedMaleNF-kappa BOrganic Anion TransportersFibrosisMacrophagesAdenine

Stichwörter der Autor:innen

AdenineAortic valve stenosisCalcificationCardiorenal syndromeChronic kidney diseaseFibrosisIndoxyl sulfateInflammationMouseNaked cuticle homologue 2Organic anion transporting polypeptide 3A1PhosphateUremiaUremic toxins

Substanzen

IndicanInterleukin-6NF-kappa BOrganic Anion TransportersUremic ToxinsIL6 protein, humaninterleukin-6, mouseAdenine

Autor:innen und Institutionen

  • Department of Internal Medicine II, Heart Center, University Hospital Bonn, Medizinische Klinik und Poliklinik II, Venusberg Campus 1, Bonn 53127, Germany.
  • Max Planck Institute for Biology of Ageing, Metabolomics Core Facility, Cologne, Germany.
  • Institute of Molecular Medicine and Experimental Immunology, University of Bonn, Bonn, Germany.
  • Kardiologie Köln, Gemeinschaftspraxis Kardiologie, Cologne, Germany.

ORCID-Profile: Philip Düsing, Ansgar Ackerschott, Sebastian Zimmer, Andreas Zietzer

Förderung

  • University of Bonn
  • German Cardiac Society
  • Corona-Foundation
  • Deutsche Forschungsgemeinschaft
  • German Federal Ministry of Education and Research

Zitieren

APA

Düsing, P., Göbel, I., Ackerschott, A., Reese, L., Giavalisco, P., Dethloff, F., Niepmann, S. T., Stei, M., Beiert, T., Zimmer, S., Kurts, C., Nickenig, G., Jansen, F., & Zietzer, A. (2025). The role of uremic toxin indoxyl sulfate in the pathophysiology of aortic valve stenosis. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf106

Vancouver

Düsing P, Göbel I, Ackerschott A, Reese L, Giavalisco P, Dethloff F, et al. The role of uremic toxin indoxyl sulfate in the pathophysiology of aortic valve stenosis. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf106

BibTeX
@article{Dsing2025,
  author = {Düsing, Philip and Göbel, Isabel and Ackerschott, Ansgar and Reese, Laurine and Giavalisco, Patrick and Dethloff, Frederik and Niepmann, Sven Thomas and Stei, Marta and Beiert, Thomas and Zimmer, Sebastian and Kurts, Christian and Nickenig, Georg and Jansen, Felix and Zietzer, Andreas},
  title = {The role of uremic toxin indoxyl sulfate in the pathophysiology of aortic valve stenosis},
  journal = {Cardiovascular Research},
  year = {2025},
  doi = {10.1093/cvr/cvaf106}
}
Kostenlos starten →